Group 1 - Aike Cyber (688719.SH) shareholders Dachen Chuangtong and Dachen Chuanghong reduced their holdings by 2,298,151 shares, accounting for 1.99% of the total share capital, and did not complete the planned reduction [1] - Benchuan Intelligent (300964.SZ) controlling shareholder Dong Xiaojun reduced his holdings by 355,787 shares, accounting for 0.4582% of the total share capital, bringing his shareholding down to 21.64% [1] - Changlian Co., Ltd. (603648.SH) completed its reduction plan by selling 3,624,050 shares, which is 1% of the total share capital [1] Group 2 - Chuan Yi Technology (002866.SZ) controlling shareholder Zou Weimin and his concerted party reduced their holdings, with Zou's shareholding dropping to 48.53% [2] - Daoshi Technology (300409.SZ) controlling shareholder Rong Jihua plans to reduce his holdings by up to 15,416,611 shares, accounting for 1.97% of the total share capital [2] - Electric Alloy (300697.SZ) completed its reduction plan by selling 2,741,390 shares, which is 0.63% of the total share capital [2] Group 3 - Fujirei (688272.SH) shareholders Suzhou Kongkong, Suzhou Zhaorong, and Shanghai Zhaoren reduced their holdings by 1,215,618 shares, 1,463,490 shares, and 44,944 shares, accounting for 1.60%, 1.93%, and 0.06% of the total share capital respectively [3] - Gaoweida (300465.SZ) controlling shareholder Yingtan Yinggao Investment Consulting Co., Ltd. reduced its holdings by 4,261,700 shares, accounting for 0.96% of the total share capital, bringing its shareholding down to 22.00% [3] - Haizheng Materials (688203.SH) shareholder Sinopec Capital plans to reduce its holdings by up to 3,525,600 shares, accounting for 1.74% of the total share capital [3] Group 4 - Hangyu Micro (300053.SZ) shareholder Yan Jun reduced his holdings by 3,930,000 shares, accounting for 0.56% of the total share capital [4] - He Shi Eye Hospital (301103.SZ) shareholder Advanced Manufacturing Industry Investment Fund plans to reduce its holdings by up to 3,106,074 shares, accounting for 2% of the total share capital [4] - He Yuan Gas (002971.SZ) shareholder Baishide Chuangye completed its reduction plan by selling 854,064 shares, which is 0.415% of the total share capital [4] Group 5 - Huaren Health (301408.SZ) shareholder Saifu Investment reduced its holdings by 2,107,696 shares, accounting for 0.53% of the total share capital [5] - Jiangsu Boyun (301003.SZ) shareholder Gong Wei reduced his holdings by 1,558,900 shares, accounting for 1.57% of the total share capital [5] - Jeya Co., Ltd. (301108.SZ) shareholders Mingyuan Fund and its concerted party did not reduce their holdings, and the reduction plan period expired [5] Group 6 - Longxin General (603766.SH) directors plan to reduce their holdings by up to 350,000 shares and 100,000 shares, accounting for 0.0170% and 0.0049% of the total share capital respectively [6] - Ruchuang Micro-Nano (688002.SH) shareholder Li Weicheng plans to reduce his holdings by up to 8,000,000 shares, accounting for 1.75% of the total share capital [6] - Shilan Micro (600460.SH) shareholder Luo Huabing plans to reduce his holdings by up to 500,000 shares, accounting for 0.03005% of the total share capital [6] Group 7 - Tongfu Microelectronics (002156.SZ) shareholder National Integrated Circuit Industry Investment Fund reduced its holdings by 15,175,969 shares, accounting for 1% of the total share capital [7] - Wangzi New Materials (002735.SZ) controlling shareholder Wang Jinjun reduced his holdings by 9,717,874 shares, accounting for 2.54% of the total share capital [7] - Xingye Co., Ltd. (603928.SH) shareholder Shen Genzhen reduced his holdings by 2,620,000 shares, accounting for 1.00% of the total share capital [7] Group 8 - Yikang Co., Ltd. (301085.SZ) controlling shareholder concerted party reduced its holdings by 633,700 shares, accounting for 0.73% of the total share capital [8] Group 9 - Yiming Pharmaceutical (002826.SZ) major shareholder Zhou Zhan reduced his holdings by 3,586,777 shares, accounting for 1.88% of the total share capital [9] - Yiming Pharmaceutical (002826.SZ) director Xi Ke reduced his holdings by 283,862 shares, accounting for 0.15% of the total share capital [9] - Youyan Powder Materials (688456.SH) concerted party reduced its holdings by 1,030,000 shares, accounting for 0.99% of the total share capital [9] Group 10 - Zhongma Transmission (603767.SH) directors plan to reduce their holdings through block trading and centralized bidding [10] - Zhongqi Co., Ltd. (301215.SZ) shareholder Jiangsu Yueda Group did not reduce its holdings, and the reduction plan period expired [10]

Core Viewpoint - The company disclosed a share reduction plan by a major shareholder, Mr. Lic, who intends to reduce his holdings by up to 300,000 shares within a specified timeframe [1] Group 1: Shareholder Reduction Details - Mr. Lic's share reduction occurred from April 1 to April 12, 2025, with an average reduction price of 11.42 yuan per share, totaling 283,862 shares, which represents 0.15% of the company's total share capital [1] - Before the reduction, Mr. Lic held 1,215,447 shares (0.64% of total share capital), and after the reduction, he holds 931,585 shares (0.49% of total share capital) [1] - The shares reduced were sourced from Mr. Lic's holdings prior to the company's initial public offering and from equity incentive shares [1] Group 2: Compliance and Governance - The reduction plan complies with relevant regulations, including self-regulatory guidelines and stock exchange rules [1] - Mr. Lic has no outstanding commitments related to share changes that have not been disclosed and fulfilled [1] - The share reduction will not lead to a change in the company's control or affect its governance structure and ongoing operations [1]

证券代码：002826 证券简称：易明医药 公告编号：2025-049 西藏易明西雅医药科技股份有限公司 关于董事减持股份计划期限届满暨实施结果的公告 董事许可先生保证向本公司提供的信息内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 近日，公司收到许可先生出具的《关于股份减持计划期限届满暨实施结果的 告知函》。截至本公告披露日，上述减持计划期限已届满，根据相关规定，现将 具体情况公告如下： 一、 股东减持情况 1、股东减持股份的情况 | 股东 | 减持 | | 减持时间 | | | 减持均价 | 减持数量 | 占总股本比例（%） | 占剔除公司回购专用账户股 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 方式 | | | | | （元/股） | （股） | | 份后总股本比例（%） | | 许可 | 集中 竞价 | 2025 2025 | 年 4 1 年 5 | 月 月 | 日至 12 日 | 11.42 | 283,862 | 0.15 | 0.15 | | 合计 | -- | | -- | | | ...

证券代码：002826 证券简称：易明医药 公告编号：2025-048 西藏易明西雅医药科技股份有限公司 关于持股 5%以上股东减持触及 1%暨减持计划期限届满的 公告 董事、持股 5%以上股东周战先生保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一 致。 西藏易明西雅医药科技股份有限公司（以下简称"公司"）于 2025年3月10 日披露了《关于公司董事、持有5%以上股东减持股份的预披露公告》（公告编 号：2025-011）。持有公司股份14,361,702股（占公司总股本比例的7.5319%）的 董事、持股5%以上股东周战先生，计划自公告披露之日起15个交易日后的3个月 内，以集中竞价方式或大宗交易方式减持公司股份不超过3,590,000股（不超过公 司总股本比例的1.8828%）。 公司于2025年6月20日披露了《关于公司持股5%以上股东减持触及1%的公 告》（公告编号：2025-046），周战先生于2025年6月11日至2025年6月18日以集 中竞价方式累计减持公司股份1,906,777股，占公司总股本 ...

证券代码：002826 证券简称：易明医药 公告编号：2025-047 西藏易明西雅医药科技股份有限公司 关于持股 5%以上股东股份提前解除质押的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 截至公告披露日，上述股东所持质押股份情况如下： 西藏易明西雅医药科技股份有限公司（以下简称"公司"）近日接到持股 5% 以上股东周战先生的通知，获悉周战先生其质押的股份提前办理了解除质押手续， 具体事项如下： 股东 名称 是否为控股 股东或第一 大股东及其 一致行动人 本次解除质 押股份数量 （股） 占其所持 股份比例 （%） 占公司总 股本比例 （%） 质押起始 日 解除日期 质权人 周战 否 2,600,000 20.88 1.36 2023 年 6 月 14 日 2025 年 6 月 20 日 广发证券股 份有限公司 周战 否 1,400,000 11.24 0.73 2023 年 6 月 20 日 2025 年 6 月 20 日 广发证券股 份有限公司 合计 -- 4,000,000 32.12 2.10 -- -- -- 一、 股东股份本次解除质押的基本 ...

Core Viewpoint - The major shareholder of Xizang Yiming Xiya Pharmaceutical Technology Co., Ltd., Mr. Zhou Zhan, has reduced his shareholding by 1% through a series of transactions, which does not affect the company's control or governance structure [1][2]. Summary by Sections Shareholder Reduction Announcement - Mr. Zhou Zhan plans to reduce his shareholding by up to 3,590,000 shares, representing 1.8828% of the total share capital, within three months from the announcement date [1]. Share Reduction Progress - From June 11 to June 18, 2025, Mr. Zhou Zhan reduced his holdings by 1,906,777 shares, accounting for 1% of the total share capital and 1.02% of the total share capital excluding shares in the repurchase account [2]. - After the reduction, Mr. Zhou Zhan holds 12,454,925 shares, which is 6.53% of the total share capital and 6.66% excluding repurchased shares [2]. Impact on Company Control - The reduction in shareholding will not lead to any change in the company's control or significantly impact its governance structure and ongoing operations [2].

证券代码：002826 证券简称：易明医药 公告编号：2025-046 西藏易明西雅医药科技股份有限公司 关于公司持股 5%以上股东减持触及 1%的公告 董事、持股 5%以上股东周战先生保证向本公司提供的信息内容真实、准确、 完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 1 | 股票简称 | 易明医药 | 股票代码 | 002826 | | | --- | --- | --- | --- | --- | | 变动方向 上升□ 下降☑ | | 一致行动人 | 有□ 无☑ | | | 是否为第一大股东或实际控制人 | | | 是□ 否☑ | | | 2．本次权益变动情况 | | | | | | 股份种类 | | 减持股数（股） | 减持比例（%） | | | （A 股、B 股等） | | | | | | A 股 | | 1,906,777 | 1 | | | 合 计 | | 1,906,777 | 1 | | | 本次权益变动方式（可 | | 通过证券交易所的集中交易 | ☑ | | | 多选） | | 通过证券交易所的大宗交易 | □ | | | ...

证券代码：002826 证券简称：易明医药 公告编号：2025-045 西藏易明西雅医药科技股份有限公司 2024 年年度权益分派实施公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有 虚假记载、误导性陈述或重大遗漏。 特别提示： 1、西藏易明西雅医药科技股份有限公司（以下简称"公司"或"本公司"）， 本次利润分配以实施分配方案时股权登记日的总股本扣除公司回购专户上的股 份为基数，向全体股东每10股派发1.00元现金红利(含税)，剩余未分配利润结转 下一年度，本年度不进行红股派送和资本公积金转增股本。截至本公告披露日， 公司总股本190,677,750股，回购专户上已回购股份3,403,800股（不享有参与利 润分配的权利）。公司本次现金分配总额=实际参与分配的总股本×分配比例= （190,677,750-3,403,800）股×0.10元/股=18,727,395元； 2、本次权益分派实施后，计算除权除息价格时，将按总股本（含回购股份） 折算每股派发现金红利，每股现金红利应以0.0982148元/股计算（每股现金红利 =现金分红总额÷公司总股本=18,727,395元÷190,677,75 ...

证券代码：002826 证券简称：易明医药 公告编号：2025-044 西藏易明西雅医药科技股份有限公司 关于 5%以上股东部分股份质押展期的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 西藏易明西雅医药科技股份有限公司（以下简称"公司"）近日接到 5%以 上股东周战先生的通知，获悉周战先生将其持有的公司部分股票办理了质押展期 业务，具体事项如下： | | 是否为 控股股 | | | | 是否 为限 售股 | 是 否 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 股东 | 东或第 | 本次质押 展期股份 | 占其所 持股份 | 占公司 总股本 | （如 | 为 | 质押起 | | 原质押 | | 质押展 | | 质权 | 质押 | | 名称 | 一大股 | 数量 | 比例 | 比例 | 是， | 补 | 始日 | | 到期日 | | 期后到 | | 人 | 用途 | | | 东 ...

Group 1 - The central bank and the State Administration of Foreign Exchange jointly issued measures to support the construction of a multi-level financial market across the Taiwan Strait, encouraging more Taiwanese enterprises to participate in the development of the mainland financial market [1] - Ant International responded that it will apply for a stablecoin license in Hong Kong as soon as possible after the "Stablecoin Regulation Draft" comes into effect on August 1 [2] - A passenger plane of Air India crashed at Ahmedabad Airport, with 242 people on board [4] Group 2 - Qingmu Technology, which has seen two consecutive trading limit increases, currently only provides e-commerce operation services for the Pop Mart Tmall flagship store [5] - Flingel has completed its verification work, and its stock will resume trading from tomorrow [5] - North Mining Technology, which has seen four consecutive trading limit increases, faces risks related to a small external circulation [5] - New China Life Insurance plans to subscribe for no more than 15 billion yuan in private equity fund shares [5] - Yiming Pharmaceutical, which has seen seven consecutive trading limit increases, has uncertainties regarding the implementation and results of its share transfer agreement [5] - Yuanlong Yatu, which has seen six trading limit increases in ten days, states that there are no significant matters that should have been disclosed but were not [5]